Profile data is unavailable for this security.
About the company
Tong Ren Tang Technologies Co Ltd is a China-based company mainly engaged in the manufacture and sale of traditional Chinese medicine products. The Company's main businesses includes the production, retail and wholesale of traditional Chinese medicine products and health care products and the provision of traditional Chinese medicine diagnosis and treatment services. The Company is also engaged in the production, processing and acquisition of Chinese herbal medicines, drug sales, medical services and advertising. The Company mainly distributes its products in the domestic market and overseas markets.
- Revenue in HKD (TTM)7.39bn
- Net income in HKD699.07m
- Incorporated2000
- Employees4.01k
- LocationTong Ren Tang Technologies Co LtdNo. 20 South Sanhuan Middle RoadFengtai DistrictBEIJING 100079ChinaCHN
- Phone+86 1 087632888
- Websitehttps://www.tongrentangkj.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Recbio Technology Co Ltd | 0.00 | -589.24m | 4.05bn | 507.00 | -- | 4.47 | -- | -- | -1.23 | -1.23 | 0.00 | 1.88 | 0.00 | -- | -- | 0.00 | -25.33 | -- | -32.84 | -- | -- | -- | -- | -- | 0.9619 | -- | 0.4548 | -- | -- | -- | 20.86 | -- | -- | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -300.71m | 4.21bn | 148.00 | -- | 4.18 | -- | -- | -1.49 | -1.49 | 0.00 | 5.01 | 0.00 | -- | -- | 0.00 | -23.80 | -- | -25.44 | -- | -- | -- | -- | -- | 5.91 | -- | 0.0296 | -- | -- | -- | 65.62 | -- | -- | -- |
| Shandong Boan Biotechnology Co Ltd | 773.25m | 66.39m | 4.60bn | 777.00 | 65.89 | 2.93 | 32.68 | 5.95 | 0.1304 | 0.1304 | 1.52 | 2.94 | 0.3069 | 1.10 | 2.60 | 951,102.70 | 2.63 | -- | 3.43 | -- | 74.10 | -- | 8.59 | -- | 1.03 | 4.01 | 0.3369 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
| Ocumension Therapeutics | 333.32m | -346.67m | 4.63bn | 477.00 | -- | 1.32 | -- | 13.88 | -0.5289 | -0.5289 | 0.5084 | 4.29 | 0.103 | 2.40 | 2.48 | 750,711.40 | -10.71 | -38.78 | -11.55 | -41.47 | 58.29 | 62.30 | -104.01 | -975.82 | 5.00 | -- | 0.0055 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
| Sihuan Pharmaceutical Holdings Group Ltd | 1.88bn | -40.60m | 6.52bn | 2.65k | -- | 1.37 | -- | 3.46 | -0.0044 | -0.0044 | 0.2031 | 0.5096 | 0.1506 | 0.894 | 3.90 | 656,234.80 | -1.77 | -6.85 | -2.68 | -9.10 | 65.91 | 75.81 | -11.78 | -36.23 | 1.50 | -- | 0.181 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
| Tong Ren Tang Technologies Co Ltd | 7.39bn | 699.07m | 6.66bn | 4.01k | 9.53 | 0.8738 | 4.76 | 0.9016 | 0.5458 | 0.5458 | 5.77 | 5.95 | 0.5026 | 0.9881 | 5.22 | 1,801,361.00 | 7.42 | 7.68 | 11.69 | 12.32 | 40.97 | 43.50 | 14.76 | 16.11 | 2.30 | -- | 0.1968 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | -0.0089 |
| Beijing Tong Ren Tang Chinese Medicine | 1.38bn | 494.14m | 6.74bn | 779.00 | 13.64 | 1.77 | 10.90 | 4.89 | 0.5903 | 0.5903 | 1.64 | 4.55 | 0.3284 | 0.3554 | 3.62 | 1,725,133.00 | 12.72 | 16.71 | 14.09 | 18.75 | 72.06 | 69.88 | 38.72 | 40.72 | 9.55 | -- | 0.0327 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
| China Shineway Pharmaceutical Group Ltd | 4.52bn | 1.19bn | 6.84bn | 3.23k | 5.27 | 0.8679 | 4.99 | 1.51 | 1.57 | 1.57 | 5.98 | 9.53 | 0.4476 | 1.28 | 5.26 | 1,314,466.00 | 11.76 | 8.03 | 15.47 | 9.77 | 75.21 | 74.55 | 26.27 | 17.87 | 3.14 | -- | 0.0457 | 36.29 | 14.32 | 11.94 | 34.14 | 13.89 | 0.6396 | 12.88 |
| Consun Pharmaceutical Group Ltd | 2.94bn | 898.46m | 7.17bn | 3.18k | 7.58 | 1.79 | 7.29 | 2.44 | 1.11 | 1.11 | 3.65 | 4.71 | 0.5209 | 2.00 | 12.89 | 940,901.90 | 15.97 | 12.04 | 23.24 | 19.25 | 74.22 | 74.55 | 30.66 | 24.89 | 2.80 | -- | 0.1144 | 40.84 | 10.71 | 7.03 | 14.88 | 11.01 | -22.93 | 18.43 |
| Yichang Hec Changjiang Pharmactcl Co Ltd | 5.95bn | 1.77bn | 8.39bn | 4.89k | 4.74 | 0.9019 | 4.09 | 1.41 | 2.01 | 2.01 | 6.76 | 10.58 | 0.4272 | 2.50 | 3.74 | 1,288,741.00 | 11.69 | 8.03 | 17.27 | 11.81 | 78.90 | 79.97 | 27.37 | 20.80 | 1.93 | 50.79 | 0.2126 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
| AIM Vaccine Co Ltd | 1.27bn | -1.28bn | 8.43bn | 1.56k | -- | 2.24 | -- | 6.63 | -1.06 | -1.06 | 1.05 | 3.11 | 0.1462 | 0.6325 | 1.10 | 783,272.40 | -22.69 | -- | -37.16 | -- | 72.34 | -- | -155.22 | -- | 0.6836 | -6.61 | 0.3437 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
| Luye Pharma Group Ltd | 6.78bn | 827.63m | 9.86bn | 5.23k | 11.91 | 0.7047 | 5.92 | 1.45 | 0.22 | 0.22 | 1.80 | 3.72 | 0.236 | 2.44 | 3.02 | 1,286,903.00 | 3.11 | 2.80 | 5.47 | 4.45 | 68.73 | 70.53 | 13.18 | 10.39 | 1.20 | 3.14 | 0.4103 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
Data as of Nov 22 2024. Currency figures normalised to Tong Ren Tang Technologies Co Ltd's reporting currency: Hong Kong Dollar HKD
17.81%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| HHLR Advisors Ltd.as of 30 Jun 2023 | 47.66m | 7.58% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 24.31m | 3.87% |
| Dimensional Fund Advisors LPas of 07 Nov 2024 | 13.63m | 2.17% |
| UBS Asset Management (Hong Kong) Ltd.as of 31 Jul 2024 | 10.57m | 1.68% |
| BlackRock Fund Advisorsas of 07 Nov 2024 | 9.32m | 1.48% |
| BlackRock Advisors (UK) Ltd.as of 08 Nov 2024 | 3.09m | 0.49% |
| SSgA Funds Management, Inc.as of 07 Nov 2024 | 981.00k | 0.16% |
| American Century Investment Management, Inc.as of 07 Nov 2024 | 932.01k | 0.15% |
| Thrivent Asset Management LLCas of 31 Jul 2024 | 794.00k | 0.13% |
| Mellon Investments Corp.as of 07 Nov 2024 | 694.89k | 0.11% |
More ▼
Data from 27 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
